Byotrol PLC – BYOT – Trading Update
Byotrol (AIM:BYOT) the specialist infection and prevention control company, is pleased to announce an update on trading.
Byotrol (AIM:BYOT) the specialist infection and prevention control company, is pleased to announce an update on trading.
We are somewhat surprised by the decline in the share price of Byotrol given the fact that it is involved in infection prevention and control.
Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, is pleased to announce today its interim results for the six months ended 30 September 2020.
Trading for the current financial year to 31 March 2021 remains strong across the whole Group and multiple opportunities continue to be available, across both product sales and IP licensing.
We have seen a very substantial increase in demand for the full range of our infection prevention and control technologies over the last seven weeks, following broad recognition of the COVID-19 outbreak in Europe. Firm orders currently sit at £1.7m for deliveries to end of June, with many more orders still being processed. Historically our order book at this time of year has been around £0.35m
Byotrol Plc (AIM: BYOT), the anti-microbial technology company, is pleased to announce today its interim results for the six months ended 30 September 2019.
Byotrol plc, the AIM quoted anti-microbial technology company, is pleased to announce the appointment of Nic Hellyer as CFO and Executive Director of the Company with immediate effect.
Byotrol, the specialist anti-microbial technology company is pleased to announce an update on its trading for the year ended 31st March 2019.
Byotrol plc the AIM listed anti-microbial technology company, is pleased to present its unaudited interim results for the six months ended 30 September 2018.
Byotrol is pleased to announce good progress over the last 12 months and provides a trading update for the year